Clinical validation of the cobas 4800 HPV test for cervical screening purposes
- PMID: 21880968
- PMCID: PMC3209101
- DOI: 10.1128/JCM.05552-11
Clinical validation of the cobas 4800 HPV test for cervical screening purposes
Abstract
This study shows that the clinical performance and reproducibility of the cobas 4800 HPV test for high-risk human papillomavirus (HPV) detection fulfill the criteria as formulated in international guidelines of HPV test requirements for cervical screening purposes. Accordingly, the cobas 4800 HPV test can be considered clinically validated for cervical screening.
References
-
- Mateos M. L., de Chacon A. J., Rodriguez-Dominguez M., Sanz I., Rubio M. D. 2011. Evaluation of a prototype real-time PCR assay for the separate detection of human papilloma virus genotypes 16 and 18 and other high risk human papillomavirus in cervical cancer screening. Enferm. Infecc. Microbiol. Clin. 29:411–414 - PubMed
-
- Meijer C. J., Berkhof H., Heideman D. A., Hesselink A. T., Snijders P. J. 2009. Validation of high-risk HPV tests for primary cervical screening. J. Clin. Virol. 46(Suppl. 3):S1–S4 - PubMed
